Santa Monica, CA, United States of America

Camille Gleason

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amgen Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Camille Gleason. Retrieved from https://idiyas.com/inventor/camille-gleason

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Camille Gleason

Introduction

Camille Gleason is a notable inventor based in Santa Monica, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable formulations that enhance the efficacy of biologically active proteins. Her work is essential in advancing medical treatments and improving patient outcomes.

Latest Patents

Camille holds 1 patent for her innovative pharmaceutical formulation. This patent focuses on a stable pharmaceutical formulation that comprises a biologically active protein and an excipient selected from carnitine, creatine, or creatinine. This formulation is crucial for ensuring the stability and effectiveness of therapeutic proteins.

Career Highlights

Camille is currently employed at Amgen Inc., a leading biotechnology company known for its commitment to developing innovative therapies. Her role at Amgen allows her to work on cutting-edge research and contribute to the advancement of biopharmaceuticals.

Collaborations

Throughout her career, Camille has collaborated with talented professionals, including Christopher James Sloey and Tiansheng Li. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Camille Gleason's contributions to pharmaceutical formulations exemplify her dedication to innovation in the medical field. Her work not only enhances the stability of therapeutic proteins but also plays a vital role in improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…